Zoledronic Acid Injection, Solution
Product Images NDC 55150-283

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 55150-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2. Therapeutic Response/serum Alkaline Phosphatase (sap) Normalization Over Time (Zoledronic Acid Fig1)

Figure 2. Therapeutic Response/serum Alkaline Phosphatase (sap) Normalization Over Time (Zoledronic Acid Fig1)
Two bar charts showing therapeutic response rate and serum alkaline phosphatase (SAP) normalization rate over time (days 10, 28, 63, 91, 182) comparing Zoledronic Acid and Risedronate. Zoledronic Acid consistently shows higher percentages at each time point, with statistically significant differences (P < 0.001) marked by asterisks.*
FDA Label Image

Package Label-principal Display Panel (5 mg per 100 mL (0.05 mg / mL))

Package Label-principal Display Panel (5 mg per 100 mL (0.05 mg / mL))
Label for Zoledronic Acid Injection 5 mg per 100 mL (0.05 mg/mL) sterile solution for intravenous infusion. The label includes dosage strength, administration instructions, storage conditions, and distributor information for AuroMedics Pharma LLC. It also features a barcode and reference to the package insert for detailed dosing and administration.*
FDA Label Image

Package Label-principal Display Panel (5 mg per 100 mL (0.05 mg / mL))

Package Label-principal Display Panel (5 mg per 100 mL (0.05 mg / mL))
Carton label for Zoledronic Acid Injection 5 mg per 100 mL (0.05 mg/mL) solution for intravenous infusion. The label indicates a single bottle of sterile solution distributed by AuroMedics Pharma LLC. It includes instructions about storage, usage, and cautions such as not mixing with calcium-containing solutions. The label also instructs to dispense the accompanying Medication Guide to each patient and notes the product is Rx only with NDC 55150-283-99.*
FDA Label Image

Zoledronic Acid Monohydrate Chemical Structure (Zoledronic Acid Str)

Zoledronic Acid Monohydrate Chemical Structure (Zoledronic Acid Str)
Chemical structure of Zoledronic Acid showing its pyrimidine ring and bisphosphonate groups, including phosphonate (PO3H2) moieties, a hydroxyl group, and water molecule (H2O) association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.